Insider Trading July 13, 2026 08:31 PM

Heartflow Executive Unloads Shares Under Pre-Arranged Plan

CEO John Farquhar's transaction follows strong quarterly results and an analyst upgrade, though the stock has faced recent downward pressure.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
HTFL

Heartflow Inc. CEO John C.M. Farquhar executed a sale of 22,562 shares on July 10, 2026, totaling $626,095 at $27.75 per share. This transaction occurred under a Rule 10b5-1 plan established in September 2025. The sale coincides with positive financial developments, including a first-quarter 2026 earnings beat and a sustained Overweight rating from Piper Sandler, despite the stock experiencing a 25% decline over the preceding six months.

Heartflow Executive Unloads Shares Under Pre-Arranged Plan
HTFL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO John Farquhar sold 22,562 shares for $626,095 at $27.75 per share under a Rule 10b5-1 plan adopted in September 2025.
  • HeartFlow reported Q1 2026 EPS of -$0.16, beating estimates of -$0.22 by 27.27%, with revenue growing 41% year-over-year to $52.6 million.
  • Piper Sandler maintains an Overweight rating with a $38.00 price target, citing strategic pricing in the FFR-CT business to boost volume.

Heartflow Inc. (NASDAQ: HTFL) Chief Executive Officer John C.M. Farquhar recently completed a transaction involving the sale of company equity. On July 10, 2026, Farquhar sold 22,562 shares of the company's common stock. The total value of this transaction reached $626,095, executed at a price of $27.75 per share. Notably, this execution price sits above the stock's current trading level of $26.16.

Following the completion of this sale, Farquhar's direct holdings in Heartflow common stock total 435,373 shares. The transaction was facilitated through a Rule 10b5-1 trading plan, which the executive adopted on September 12, 2025. This type of pre-arranged plan is typically used to manage insider transactions in compliance with securities regulations.

The insider activity occurs against a backdrop of mixed market performance for the stock. Over the past six months, the share price has declined by 25%. Despite this recent downward trend, analysis from InvestingPro suggests that the company might be overvalued at its current price point based on Fair Value assessments. This valuation perspective contrasts with the recent price action, highlighting the complex dynamics influencing the stock.

Financially, HeartFlow Inc. has demonstrated strong operational momentum. The company reported its first-quarter 2026 earnings, which surpassed analyst expectations. The earnings per share (EPS) came in at -$0.16, a significant improvement from the anticipated -$0.22. This represents a positive surprise of 27.27% for investors.

Revenue performance also showed robust growth. The company's revenue reached $52.6 million, marking a 41% increase year-over-year. This financial expansion is attributed to strong global case volume growth. The operational success has not gone unnoticed by market analysts. Piper Sandler has maintained an Overweight rating on HeartFlow, keeping a price target of $38.00. Analyst Matt O'Brien highlighted that strategic pricing concessions in the FFR-CT business are intentionally driving volume growth.

Investors seeking deeper insights can access additional InvestingPro Tips and comprehensive Pro Research Reports. The combination of insider selling, valuation metrics, and strong financial results presents a multifaceted picture of the company's current standing.

Risks

  • The stock has declined 25% over the past six months, indicating recent downward pressure despite positive earnings.
  • InvestingPro analysis suggests the company may be overvalued at current levels based on Fair Value assessment, posing a valuation risk.
  • The reliance on strategic pricing concessions to drive volume growth in the FFR-CT business introduces uncertainty regarding margin sustainability.

More from Insider Trading

RH Director Mark S. Demilio Executes $411,826 Stock Disposition Amid Valuation Debate Jul 13, 2026 Yext Director Daniel Englander Acquires $397,909 in Company Stock Jul 13, 2026 CrowdStrike CEO George Kurtz Executes $3.86M Share Divestiture Amid Analyst Revisions Jul 13, 2026 Planet Labs CEO Offloads $5.18M in Equity Under Pre-Arranged Plan Jul 13, 2026 Planet Labs Executive Offloads Shares Amid Valuation Debate and Expansion Jul 13, 2026